Saroja Pharma Industries India
Saroja Pharma Industries India Performance
Day Range
- Low 61.25
- High 61.55
52 Week Range
- Low 55.00
- High 82.90
- Open Price61.55
- Previous Close61.75
- Volume3200
Start SIP in Saroja Pharma Industries India
Start SIPSaroja Pharma Industries India Investment Rating
-
Master Rating:
-
Saroja Pharma Industries India Ltd has an operating revenue of Rs. 159.57 Cr. on a trailing 12-month basis. An annual revenue de-growth of -10% needs improvement, Pre-tax margin of 3% needs improvement, ROE of 20% is exceptional. The company has a debt to equity of 55%, which is bit higher. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 11 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 149 indicates it belongs to a poor industry group of Medical-Supplies and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Mar 2023 | Mar 2022 |
|---|---|---|
| Total Revenue Annual Cr | 50 | 56 |
| Operating Expenses Annual Cr | 47 | 54 |
| Operating Profit Annual in Cr | 3 | 2 |
| Depreciation Cr | 0 | 0 |
| Interest Annual Cr | 1 | 1 |
| Tax Annual Cr | 0 | 0 |
| Net Profit Annual Cr | 1 | 1 |
Saroja Pharma Industries India Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 9
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹60.63
- 50 Day
- ₹
- 100 Day
- ₹
- 200 Day
- ₹
- 20 Day
- ₹60.54
- 50 Day
- ₹
- 100 Day
- ₹
- 200 Day
- ₹
Saroja Pharma Industries India Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 61.45 |
| Second Resistance | 61.65 |
| Third Resistance | 61.75 |
| RSI | 50.79 |
| MFI | 50.89 |
| MACD Single Line | -1.58 |
| MACD | -1.14 |
| Support | |
|---|---|
| First Resistance | 61.15 |
| Second Resistance | 61.05 |
| Third Resistance | 60.85 |
Saroja Pharma Industries India Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 3,200 | 320,000 | 100 |
| Week | 3,200 | 266,656 | 83.33 |
| 1 Month | 4,267 | 346,667 | 81.25 |
| 6 Month | 4,467 | 401,914 | 89.97 |
Saroja Pharma Industries India Result Highlights
Saroja Pharma Industries India Synopsis
NSE-Medical-Supplies
Saroja Pharma Indust belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 50.19 Cr. and Equity Capital is Rs. 2.94 Cr. for the Year ended 31/03/2023. Saroja Pharma Industries India Ltd. is a Public Limited Listed company incorporated on 14/01/2019 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is U24110MH2019PLC319508 and registration number is 319508.| Market Cap | 25 |
| Sales | 50 |
| Shares in Float | 0.11 |
| No of funds | |
| Yield |
| Book Value | 3.53 |
| U/D Vol ratio | 0.6 |
| LTDebt / Equity | 55 |
| Alpha | -0.19 |
| Beta | 1.24 |
Saroja Pharma Industries India
| Owner Name | Sep-23 |
|---|---|
| Promoters | 73.02% |
| Individual Investors | 24.32% |
| Others | 2.66% |
Saroja Pharma Industries India Management
| Name | Designation |
|---|---|
| Mr. Biju Gopinathan Nair | Chairman & Managing Director |
| Mr. Manish Dasharath Kamble | Whole Time Director |
| Mr. Pulinattu Nandakumar | Non Executive Director |
| Mr. Abhishek Agrawal | Independent Director |
| Ms. Pinky Kataruka | Independent Director |
| Ms. Sonal Jain | Independent Director |
Saroja Pharma Industries India Forecast
Price Estimates
Saroja Pharma Industries India FAQs
What is Share Price of Saroja Pharma Industries India ?
Saroja Pharma Industries India share price is ₹61 As on 03 December, 2023 | 10:22
What is the Market Cap of Saroja Pharma Industries India ?
The Market Cap of Saroja Pharma Industries India is ₹24.6 Cr As on 03 December, 2023 | 10:22
What is the P/E ratio of Saroja Pharma Industries India ?
The P/E ratio of Saroja Pharma Industries India is As on 03 December, 2023 | 10:22
What is the PB ratio of Saroja Pharma Industries India ?
The PB ratio of Saroja Pharma Industries India is 4.8 As on 03 December, 2023 | 10:22